Blocking HIV replication by targeting Tat protein

Chemistry and Biology

Volumn 7, Issue 9, 2000, Pages 669-676

  Hamy, François ^a   Gelus, Nathalie ^b   Zeller, Marco ^c   Lazdins, Janis L ^a   Bailly, Christian ^b   Klimkait, Thomas ^d  

^a NOVARTIS PHARMA AG   (Switzerland)

^b INSERM   (France)

^c SOLVIAS AG   (Switzerland)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

CXCR4 coreceptor; HIV infection; Tat inhibition

Indexed keywords

AMIDE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BETA GALACTOSIDASE; CGA 137053; CHEMOKINE RECEPTOR CXCR4; HYBRID PROTEIN; IMIDAZOLE DERIVATIVE; TRANSACTIVATOR PROTEIN; VIRUS RNA;

ARTICLE; CD4+ T LYMPHOCYTE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; LYMPHOCYTE; MACROPHAGE; METABOLISM; PHYSIOLOGY; TRANSACTIVATION; VIROLOGY; VIRUS REPLICATION;

AMIDES; ANTI-HIV AGENTS; BETA-GALACTOSIDASE; CD4-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAT; HELA CELLS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; IMIDAZOLES; LYMPHOCYTES; MACROPHAGES; MODELS, MOLECULAR; NUCLEIC ACID CONFORMATION; RECEPTORS, CXCR4; RECOMBINANT FUSION PROTEINS; RNA, VIRAL; TRANS-ACTIVATION (GENETICS); VIRUS REPLICATION;

ANIMALIA; DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033830893     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(00)00012-0     Document Type: Article

References (17)

1. Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands
2. An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication
3. Rational optimization of a HIV-1 Tat inhibitor: Rapid progress on combinatorial lead structures
4. A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition
5. Dissecting the mode of action of various HIV-inhibitor classes in a stable cellular system
6. Tat as one key to HIV-induced immune pathogenesis and Pat toxoid as an important component of a vaccine
7. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and t-lymphotropic HIV-1 strains
8. The structure of the human immunodifeciency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein
9. Methylphosphonate mapping of phosphate contacts critical for RNA recognition by the human immunodeficiency virus tat and rev proteins
10. Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 Tat protein recognition of TAR RNA
11. TAR RNA binding by HIV-1 Tat protein is selectively inhibited by its L-enantiomer
12. Novel sulfonated and phosphonated analogs of distamycin which inhibit the replication of HIV
13. Control of SHIV-89.6P-infection of cynomolgous monkeys by HIV-1 Tat protein vaccine
14. Acute oral, dermal, and inhalation studies
15. High affinity binding of TAR RNA by the human immunodeficiency virus type-1 tat protein requires base-pairs in the RNA stem and amino acid residues flanking the basic region
16. In vitro effect of transforming growth factor-beta on progression of HIV-1 infection in primary mononuclear phagocytes
17. CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activity